MULTIPLE THERAPIES, ONE VIRUS Trademark

Trademark Overview

On Wednesday, December 1, 2021, a trademark application was filed for MULTIPLE THERAPIES, ONE VIRUS with the United States Patent and Trademark Office. The USPTO has given the MULTIPLE THERAPIES, ONE VIRUS trademark a serial number of 97150701. The federal status of this trademark filing is REGISTERED as of Tuesday, February 3, 2026. This trademark is owned by KALIVIR IMMUNOTHERAPEUTICS, INC.. The MULTIPLE THERAPIES, ONE VIRUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the fields of immunotherapy, immunotherapeutics, biotechnology, and biopharmaceuticals; immunotherapeutic and biopharmaceutical drug development services
multiple therapies, one virus

General Information

Serial Number97150701
Word MarkMULTIPLE THERAPIES, ONE VIRUS
Filing DateWednesday, December 1, 2021
Status700 - REGISTERED
Status DateTuesday, February 3, 2026
Registration Number8128341
Registration DateTuesday, February 3, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesMedical and scientific research in the fields of immunotherapy, immunotherapeutics, biotechnology, and biopharmaceuticals; immunotherapeutic and biopharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code042
First Use Anywhere DateMonday, December 7, 2020
First Use In Commerce DateMonday, December 7, 2020

Trademark Owner History

Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238
Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238
Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238

Trademark Events

Event DateEvent Description
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Tuesday, September 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 12, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 12, 2023SOU EXTENSION 1 FILED
Monday, June 12, 2023SOU EXTENSION 1 GRANTED
Wednesday, June 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 7, 2023SOU EXTENSION 2 FILED
Thursday, December 7, 2023SOU EXTENSION 2 GRANTED
Saturday, December 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2024SOU EXTENSION 3 FILED
Monday, June 3, 2024SOU EXTENSION 3 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 10, 2024SOU EXTENSION 4 FILED
Tuesday, December 10, 2024SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 15, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, October 1, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 14, 2025SOU EXTENSION 5 FILED
Wednesday, October 1, 2025SOU EXTENSION 5 GRANTED
Thursday, October 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 15, 2025TEAS STATEMENT OF USE RECEIVED
Monday, December 15, 2025USE AMENDMENT FILED
Wednesday, December 17, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, January 12, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 12, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 3, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, February 3, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

virus therapies multiple biopharmaceutical immunotherapeutic drug development services biopharmaceuticals biotechnology research scientific fields